Key Drivers
- Strong Liquidity
- Thin Margins
- Leverage Pressure
AIAI Summary
MOH has shifted from a simple cheap managed-care name to a cash-generating, policy-backed re-rating story, but with Q1 profit nearly wiped out and earnings still highly sensitive to medical-cost and reimbursement swings, this remains a “prove-it” setup where sustained 2026 execution—not valuation alone—must validate the upside.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Liquidity
- •Thin Margins
- •Leverage Pressure
MOH remains financially solid thanks to strong liquidity and cash flow, but its thin margins and elevated leverage make earnings quality fragile.
Price Behavior
Key Price Behavior Insights:
- •Breakout rally
- •Higher lows
- •Overextended run
MOH is in a strong last-month uptrend, breaking above $200 and $216.04 while holding higher lows, but after a sharp run into the high $220s it looks extended and vulnerable to a pause unless it holds the $228.7-$229.5 support zone.
Sharp surge from the low $180s to the high $220s in last month signals elevated short-term pullback risk
Sentiment & News
Key News Insights:
- •Valuation focus
- •Medicaid expansion
- •Mixed momentum
Molina Healthcare drew attention for valuation upside and investor interest in June, highlighted by an Illinois Medicaid contract win and a 6.3% share pop, though earnings revisions still did not confirm sustained momentum.
The news is mildly positive overall, with the contract award and high-profile investor interest supporting sentiment, but follow-through depends on earnings revisions and execution
Similar Companies in Healthcare
Other companies in the same sector with AI ratings